Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Patrys Limited ( (AU:PAB) ) has issued an announcement.
Patrys Limited announced a change in the director’s interest, with Peter James Christie acquiring 833,333 unlisted options as a sub-underwriter for the company’s Entitlement Offer. This change, approved at the company’s Annual General Meeting, reflects Patrys Limited’s strategic financial maneuvers to strengthen its market position and support its ongoing projects.
More about Patrys Limited
Patrys Limited operates in the biotechnology industry, focusing on the development of novel antibody therapies. The company is known for its work on antibody-based treatments, which are designed to target and treat various diseases, including cancer. Patrys Limited is committed to advancing its research and development efforts to bring innovative therapies to the market.
Average Trading Volume: 1,623,865
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$11.93M
Learn more about PAB stock on TipRanks’ Stock Analysis page.